AbbVie Inc. Other Non-current Liabilities 2012-2026 | ABBV
Beta
What is AbbVie Inc.'s current other non-current liabilities?
AbbVie Inc. (ABBV) annual other non-current liabilities for 2025 was $32.57B, a 8.10% increase from 2024. AbbVie Inc. other non-current liabilities for the quarter ending March 31, 2026 was $34.11B.
What was AbbVie Inc.'s other non-current liabilities in 2024?
AbbVie Inc. annual other non-current liabilities for 2024 was $30.13B, a 6.80% decline from 2023.
What was AbbVie Inc.'s other non-current liabilities in 2023?
AbbVie Inc. annual other non-current liabilities for 2023 was $32.33B, a 5.45% increase from 2022.
What is AbbVie Inc.'s 5-year other non-current liabilities CAGR?
AbbVie Inc. other non-current liabilities grew at a compound annual growth rate (CAGR) of 3.36% from FY2020 to FY2025, going from $27.61B to $32.57B over 5 years.
Other Non-current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+3.4%
FY2020
$27.61B
→
FY2025
$32.57B
1213141516171819202122232425
5 years selected
Other Non-current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $32.57B | +8.1% | 10-K |
| FY2024 | $30.13B | -6.8% | 10-K |
| FY2023 | $32.33B | +5.5% | 10-K |
| FY2022 | $30.66B | +6.8% | 10-K |
| FY2021 | $28.70B | +4.0% | 10-K |
| FY2020 | $27.61B | +56.9% | 10-K |
| FY2019 | $17.60B | +1246.4% | 10-K |
| FY2018 | $1.31B | +5.3% | 10-K |
| FY2017 | $1.24B | +7.0% | 10-K |
| FY2016 | $1.16B | +37.4% | 10-K |
| FY2015 | $844.0M | -14.7% | 10-K |
| FY2014 | $990.0M | -26.0% | 10-K |
| FY2013 | $1.34B | +48.6% | 10-K |
| FY2012 | $900.0M | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →